Runzhi Liu

Runzhi Liu is a notable inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Alzheimer's disease. His work focuses on developing novel compounds that can aid in managing this debilitating condition.

Latest Patents

Runzhi Liu holds a patent for "Aromatic heterocyclic derivatives and pharmaceutical applications thereof." This patent includes aromatic heterocyclic derivatives, stereoisomers, tautomers, N-oxides, solvates, metabolites, pharmaceutically acceptable salts, and prodrugs. These compounds are specifically designed for treating Alzheimer's disease. The patent also covers pharmaceutical compositions containing these compounds and their use in managing or treating 5-HT receptor-mediated diseases.

Career Highlights

Runzhi Liu is associated with Sunshine Lake Pharma Co., Ltd., where he continues to innovate in the pharmaceutical sector. His research and development efforts are aimed at creating effective treatments for neurological disorders, showcasing his commitment to improving patient outcomes.

Collaborations

Runzhi Liu collaborates with talented colleagues, including Yingjun Zhang and Chuanfei Jin. Their combined expertise enhances the research and development efforts at Sunshine Lake Pharma Co., Ltd.

Conclusion

Runzhi Liu's innovative work in developing pharmaceutical compounds for Alzheimer's disease highlights his significant contributions to medical science. His dedication to research and collaboration with fellow scientists positions him as a key figure in the ongoing fight against neurological disorders.

Profile summary based on public USPTO records.